H Tohmo1, M Karanko. 1. Cardiorespiratory Research Unit, University of Turku, Finland.
Abstract
OBJECTIVE: The efficacy of intravenous enalaprilat in lowering postoperative hypertension. DESIGN: Prospective, randomized, controlled, single blind trial. SETTING:Surgical ICTin a university hospital (tertiary care center). PATIENTS: 18 neurosurgical patients subjected to the extirpation of a supratentorial intracerebral tumour were studied after detection of postoperative hypertension. This was defined as a constant elevation of systolic arterial pressure over 160 mmHg or diastolic arterial pressure over 95 mmHg. INTERVENTIONS:Enalaprilat 0.015 mg kg-1 was injected within 5 min to 9 patients. MEASUREMENTS AND RESULTS:Central haemodynamics and systemic oxygenation were assessed at baseline before enalaprilat injection, and repeatedly during four hours after the injection. The statistical analysis was performed with analysis of variance for repeated measurements. As compared to control patients, the blood pressure lowering effect of enalaprilat became evident within 15 min and lasted for over four hours (p = 0.008). It was mainly due to the reduced systemic vascular resistance. Enalaprilat also induced a small decline in myocardial perfusion pressure. Cardiac performance, preload, heart rate and systemic oxygenation were not affected by enalaprilat. CONCLUSIONS: We found intravenous enalaprilat effective and safe in lowering postoperative hypertension following neurosurgery as assessed by it's effects on central haemodynamics and systemic oxygenation.
RCT Entities:
OBJECTIVE: The efficacy of intravenous enalaprilat in lowering postoperative hypertension. DESIGN: Prospective, randomized, controlled, single blind trial. SETTING: Surgical ICT in a university hospital (tertiary care center). PATIENTS: 18 neurosurgical patients subjected to the extirpation of a supratentorial intracerebral tumour were studied after detection of postoperative hypertension. This was defined as a constant elevation of systolic arterial pressure over 160 mmHg or diastolic arterial pressure over 95 mmHg. INTERVENTIONS:Enalaprilat 0.015 mg kg-1 was injected within 5 min to 9patients. MEASUREMENTS AND RESULTS: Central haemodynamics and systemic oxygenation were assessed at baseline before enalaprilat injection, and repeatedly during four hours after the injection. The statistical analysis was performed with analysis of variance for repeated measurements. As compared to control patients, the blood pressure lowering effect of enalaprilat became evident within 15 min and lasted for over four hours (p = 0.008). It was mainly due to the reduced systemic vascular resistance. Enalaprilat also induced a small decline in myocardial perfusion pressure. Cardiac performance, preload, heart rate and systemic oxygenation were not affected by enalaprilat. CONCLUSIONS: We found intravenous enalaprilat effective and safe in lowering postoperative hypertension following neurosurgery as assessed by it's effects on central haemodynamics and systemic oxygenation.